The European Medicines Agency (EMA) initiated a public consultation process and sought feedback on two important documents: the Regulatory Science Research Needs (RSRN) and the concept paper for the European Platform for Regulatory Science Research:

  1. The 2024 update of the Regulatory Science Research Needs
  2. A draft concept paper on the European Platform for Regulatory Science Research